NCT06865066

Brief Summary

The goal of this clinical trial is to design an online Cognitive Behavioural Therapy (CBT) and Acceptance Commitment Therapy (ACT) program and to learn if it can treat anxiety in women transitioning into menopause (perimenopause). The main questions it aims to answer are:

  • Is our online psychotherapy program a practical and acceptable means of managing anxiety during perimenopause?
  • Does our online psychotherapy program work in improving anxiety levels during perimenopause? Participants will participate in weekly e-CBT module sessions tailored to perimenopausal anxiety and will be given weekly feedback on assignments from trained care providers through a secure online platform. Participants will complete questionnaires at the beginning, middle, and at end of the study, as well as at the three and six-month follow-up.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 11, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 3, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 7, 2025

Completed
Last Updated

March 7, 2025

Status Verified

February 1, 2025

Enrollment Period

4 months

First QC Date

March 3, 2025

Last Update Submit

March 3, 2025

Conditions

Keywords

MenopauseAnxietyOnline Psychotherapye-CBTCBTACTMenopause TransitionDigital TherapyPerimenopausePerimenopausal Anxiety

Outcome Measures

Primary Outcomes (1)

  • Change in symptoms (Generalized Anxiety Disorder - 7 Item)

    Clinically validated symptom questionnaire. Scale of 0-3, 3 being the worst.

    Week 0, week 4, week 9, 3 and 6-month follow-up

Secondary Outcomes (7)

  • Change in symptoms (Menopausal Rating Scale)

    Week 0, week 4, week 9, 3 and 6-month follow-up

  • Change in symptoms (Depression Anxiety Scale - 21 Item)

    Week 0, week 4, week 9, 3 and 6-month follow-up

  • Change in symptoms (The Menopause-specific Quality of Life)

    Week 0, week 4, week 9, 3 and 6-month follow-up

  • Change in symptoms (Center for Epidemiologic Studies Depression Scale)

    Week 0, week 4, week 9, 3 and 6-month follow-up

  • Change in symptoms (Pittsburgh Sleep Quality Index)

    Week 0, week 4, week 9, 3 and 6-month follow-up

  • +2 more secondary outcomes

Study Arms (1)

Online psychotherapy treatment arm

EXPERIMENTAL

All participants will receive access to e-CBT modules offered through the Online Psychotherapy Tool (OPTT) and will be paired with an online careprovider, who is trained to administer online CBT and ACT. Following the structure of previous e-CBT modules developed by the QUOPL team, the module for this study will be designed to mirror standard in-person CBT for Generalized Anxiety Disorder and will combine components of ACT. Weekly homework will be assigned and evaluated by the participant's designated care provider, who will provide personalized feedback on the online platform (OPTT), acknowledging their module completion and homework

Behavioral: e-CBT

Interventions

e-CBTBEHAVIORAL

Electronically delivered cognitive behavioural therapy with acceptance commitment therapy components

Online psychotherapy treatment arm

Eligibility Criteria

Age40 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • In perimenopausal staging (as defined by the STRAW +10 criteria)
  • Assigned female at birth
  • Diagnosis of GAD according to DSM-5 by attending psychiatrist on research team
  • Competence to consent to participate
  • Ability to speak and read English
  • Consistent and reliable access to the internet

You may not qualify if:

  • Undergone CBT or hormone therapy within the last 6 months will be excluded
  • Active psychosis
  • Acute mania
  • Severe alcohol or substance use disorder
  • Active suicidal or homicidal ideation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kingston General Hospital

Kingston, Ontario, K7L 5G3, Canada

RECRUITING

Nazanin Alavi

Kingston, Ontario, K7L 5G3, Canada

RECRUITING

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Nazanin Alavi, MD, FRCPC

    Queen's University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nazanin Alavi, MD, FRCPC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This one-arm trial will deliver e-CBT for perimenopausal anxiety using the Online Psychotherapy Tool (OPTT), a secure, cloud-based digital mental health platform. All participants will be enrolled in a 9-week e-CBT/e-ACT program specifically designed to address perimenopausal anxiety. Each week, they will complete structured e-modules and homework assignments while receiving personalized feedback and asynchronous support from a therapist through the platform. The program consists of 9 weekly sessions, each containing approximately 30 e-module slides with interactive content, all delivered through OPTT. This structured approach aims to help participants effectively manage their anxiety symptoms during perimenopause.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator, Assistant Professor

Study Record Dates

First Submitted

March 3, 2025

First Posted

March 7, 2025

Study Start

November 11, 2024

Primary Completion

February 28, 2025

Study Completion

February 28, 2025

Last Updated

March 7, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Results will be shared through conference presentations, workshops, and journal publications.

Locations